Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Gemcitabine/Oxaliplatin and Cetuximab in Locally Advanced Pancreatic Cancer
NCT00408564Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Jan 2006
- Primary completion
- Apr 2013
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in pancreatic cancer (PC), sponsored by Medical University of South Carolina. Started Jan 2006; status: completed.
02
Drugs
cetuximab
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00408564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00408564.